Reading Time: 3 minutesA recently published paper, reviewing 15 studies that investigated the effectiveness of riluzole as a treatment for MND in real-time, has suggested that the drug
Month: July 2020
![](https://sp-ao.shortpixel.ai/client/to_webp,q_glossy,ret_img,w_800,h_586/https://mndresearch.blog/wp-content/uploads/2020/07/covid-19-5340230_1280-2787864266-1595233446770.png)
Reading Time: 4 minutesGuest researcher blog post: My name is Sophie Nyberg and I am a neuroscientist currently working in the Lighthouse COVID-19 testing labs in Alderley Park,
![](https://sp-ao.shortpixel.ai/client/to_webp,q_glossy,ret_img,w_800,h_450/https://mndresearch.blog/wp-content/uploads/2020/07/dna-gene.jpg)
Reading Time: 5 minutesLast Thursday marked an exciting milestone in the search for effective therapies for MND as full results from the early-phase 1/2 trial of Biogen’s tofersen
![](https://sp-ao.shortpixel.ai/client/to_webp,q_glossy,ret_img,w_800,h_420/https://mndresearch.blog/wp-content/uploads/2020/06/destination-1285851_1280-2004056010-1594112266471.png)
Reading Time: 4 minutesAlthough ALS is a neurodegenerative disease, researchers are increasingly also interested in events happening outside the brain and spinal cord, in particular whether changes in